Insights
Into cervical
cancer risk

Co-testing with Pap and HPV together for superior detection of risk versus either test alone1-3

Making sure that your patients are screened for cervical cancer is a critical component of their overall health. A recent study demonstrated that co-testing with Pap and HPV together has consistently and repeatedly identified more cases of precancer and cancer than either Pap or HPV testing alone.3 A more accurate look at the risk of cervical cancer for women ages 30 to 65 starts with co-testing—a Pap test plus an HPV test on the same sample.

Comprehensive testing from Quest Diagnostics

For more than 50 years, we’ve been committed to providing diagnostic insights that can help you and your patients work together for better health. You can count on Quest for co-testing solutions that give you a more complete picture to help you make more informed decisions. We offer:

Cervical cancer screenings based on guidelines from many leading health societies
 
Aged-based Smart Codes provide cervical cancer screening based on ACOG guidelines and STI testing as appropriate
 
Liquid-based Pap tests to detect abnormal cells on the cervix
 
Aptima® HPV mRNA testing to detect presence and activity of infection
Enhanced reporting with CytoComplete for integrated, streamlined results for Pap and HPV
 
Biopsy confirmation of current and prior Pap results so a re-biopsy can be recommended when appropriate
 
Patient resources that drive engagement

Test ordering information

For more information on the following tests, or for a complete list of available tests, click below to visit our test directory.

Test code Test name
90933 ThinPrep® Imaging Pap and HPV mRNA E6/E7
90934 ThinPrep® Imaging Pap reflex HPV mRNA E6/E7
91384 Image-Guided Pap with Age-Based Screening Protocols
91385 Image-Guided Pap with Age-Based Screening with CT/NG
91386 Image-Guided Pap with Age-Based Screening with CT/NG, Trichomonas
References
  1. Blatt AJ, Kennedy R, Luff RD, Austin RM, Rabin DS. Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices. Cancer Cytopathol. 2015;123:282-288. doi: 10.1002/cncy.21544
  2. Quest Diagnostics. Data on file. 2015.
  3. Austin RM, Onisko A, Zhao C. Enhanced detection of cervical cancer and precancer through use of imaged liquid-based cytology in routine cytology and HPV cotesting. Am J Clin Pathol. 2018;150(5):385-392. doi: 10.1093/ajcp/aqy114